308 related articles for article (PubMed ID: 35183868)
1. Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study.
Huang Y; Tang J; Wang H; Yu H; Song Q; Guo X; Li C; Wang J; Liang C; Li S; Li S; Lin Z; Chen Q; Zhong G; Zhuang S; Su Y; Li T; Wu T; Ge S; Zhang J; Xia N
EBioMedicine; 2022 Mar; 77():103885. PubMed ID: 35183868
[TBL] [Abstract][Full Text] [Related]
2. Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population.
Huang Y; Li T; Yu H; Tang J; Song Q; Guo X; Wang H; Li C; Wang J; Liang C; Yao X; Qiu L; Zhuang C; Bi Z; Su Y; Wu T; Ge S; Zhang J
Emerg Microbes Infect; 2021 Dec; 10(1):1824-1831. PubMed ID: 34392819
[TBL] [Abstract][Full Text] [Related]
3. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus (CMV) seroprevalence among women at childbearing age, maternal and congenital CMV infection: policy implications of a descriptive, retrospective, community-based study.
Ben Shoham A; Schlesinger Y; Miskin I; Kalderon Z; Michaelson-Cohen R; Wiener-Well Y
Isr J Health Policy Res; 2023 Apr; 12(1):16. PubMed ID: 37098565
[TBL] [Abstract][Full Text] [Related]
5. Reconsideration of Maternal Serological Testing for Predicting Congenital CMV Infection.
Huang Y; Tang J; Yu H; Song Q; Hao M; Wang H; Liu J; Dong Y; Liang M; Zhuang S; Li C; Wang J; Liang C; Su Y; Li T; Wu T; Ge S; Zhang J; Xia N
J Infect Dis; 2024 Jun; 229(6):1817-1822. PubMed ID: 37738651
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus DNA detection in pregnant women with a high IgG avidity index: a valuable tool for diagnosing non-primary infections?
Karageorgou I; Kossyvakis A; Jiménez J; Garcia I; Mentis AA
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9399-9405. PubMed ID: 35139746
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study).
Lilleri D; Tassis B; Pugni L; Ronchi A; Pietrasanta C; Spinillo A; Arossa A; Achille C; Vergani P; Ornaghi S; Riboni S; Cavoretto P; Candiani M; Gaeta G; Prefumo F; Fratelli N; Fichera A; Vignali M; Barbasetti Di Prun A; Fabbri E; Cetin I; Locatelli A; Consonni S; Rutolo S; Miotto E; Savasi V; Di Giminiani M; Cromi A; Binda S; Fiorina L; Furione M; Cassinelli G; Klersy C;
Clin Infect Dis; 2023 Feb; 76(3):513-520. PubMed ID: 35717635
[TBL] [Abstract][Full Text] [Related]
8. Congenital Human Cytomegalovirus Infection Is Associated With Decreased Transplacental IgG Transfer Efficiency Due to Maternal Hypergammaglobulinemia.
Semmes EC; Li SH; Hurst JH; Yang Z; Niedzwiecki D; Fouda GG; Kurtzberg J; Walsh KM; Permar SR
Clin Infect Dis; 2022 Apr; 74(7):1131-1140. PubMed ID: 34260701
[TBL] [Abstract][Full Text] [Related]
9. Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China.
Wang S; Wang T; Zhang W; Liu X; Wang X; Wang H; He X; Zhang S; Xu S; Yu Y; Jia X; Wang M; Xu A; Ma W; Amin MM; Bialek SR; Dollard SC; Wang C
Medicine (Baltimore); 2017 Feb; 96(5):e6007. PubMed ID: 28151899
[TBL] [Abstract][Full Text] [Related]
10. Maternal and neonatal anti-cytomegalovirus IgG level and risk of postnatal cytomegalovirus transmission in preterm infants.
Nijman J; van Loon AM; Krediet TG; Verboon-Maciolek MA
J Med Virol; 2013 Apr; 85(4):689-95. PubMed ID: 23296599
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Maternal Cytomegalovirus Antibodies and Neonatal Congenital Cytomegalovirus at Less than 34 Weeks of Gestation: A Prospective Study.
Kalane SU; Raste L; Patwardhan S; Beasley DA; Devaskar UP
Am J Perinatol; 2024 May; 41(S 01):e648-e653. PubMed ID: 36261064
[TBL] [Abstract][Full Text] [Related]
12. Risk of congenital cytomegalovirus infection in children born to women with IgG avidity in the grey zone during first trimester of pregnancy.
Kekkou K; Kavatha D; Karalexi M; Galani L; Dimopoulou D; Papaevangelou V; Antoniadou A
J Matern Fetal Neonatal Med; 2021 Jun; 34(12):2025-2029. PubMed ID: 31401915
[TBL] [Abstract][Full Text] [Related]
13. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
[TBL] [Abstract][Full Text] [Related]
14. Hearing outcome in congenitally CMV infected children in Finland - Results from follow-up after three years age.
Puhakka L; Lappalainen M; Lönnqvist T; Nieminen T; Boppana S; Saxen H; Niemensivu R
Int J Pediatr Otorhinolaryngol; 2022 May; 156():111099. PubMed ID: 35276528
[TBL] [Abstract][Full Text] [Related]
15. Revision of Cytomegalovirus Immunoglobulin M Antibody Titer Cutoff in a Maternal Antibody Screening Program in Japan: A Cohort Comparison Involving a Total of 32,000 Pregnant Women.
Kitamura A; Toriyabe K; Hagimoto-Akasaka M; Hamasaki-Shimada K; Ikejiri M; Minematsu T; Suga S; Kondo E; Kihira M; Morikawa F; Ikeda T
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112942
[TBL] [Abstract][Full Text] [Related]
16. Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.
Mussi-Pinhata MM; Yamamoto AY
J Infect Dis; 2020 Mar; 221(Suppl 1):S15-S22. PubMed ID: 32134482
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of pre-existing natural immunity in a nonhuman primate reinfection model of congenital cytomegalovirus infection.
Moström M; Yu S; Tran D; Saccoccio F; Versoza CJ; Malouli D; Mirza A; Valencia S; Gilbert M; Blair R; Hansen S; Barry P; Früh K; Jensen JD; Pfeifer SP; Kowalik TF; Permar SR; Kaur A
bioRxiv; 2023 Apr; ():. PubMed ID: 37090643
[TBL] [Abstract][Full Text] [Related]
18. Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.
Gantt S; Leister E; Jacobsen DL; Boucoiran I; Huang ML; Jerome KR; Jourdain G; Ngo-Giang-Huong N; Burchett S; Frenkel L
J Med Virol; 2016 Jun; 88(6):1051-8. PubMed ID: 26519647
[TBL] [Abstract][Full Text] [Related]
19. Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study.
Barlinn R; Dudman SG; Trogstad L; Gibory M; Muller F; Magnus P; Rollag H
APMIS; 2018 Dec; 126(12):899-906. PubMed ID: 30378168
[TBL] [Abstract][Full Text] [Related]
20. Establishing correlates of maternal-fetal cytomegalovirus transmission-one step closer through predictive modeling.
Marchant A; Adali S; Alsdurf H; Bol V; Capelle X; De Schrevel N; Delroisse JM; Devlieger R; Dieussaert I; Donner C; Janssens M; Loquet P; Panackal AA; Seidl C; van den Berg RA; Paris R
J Infect Dis; 2024 Jun; ():. PubMed ID: 38865084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
